Alteration of cytokines in serum and cerebrospinal fluid before and after high-dose immunoglobulin therapy in patients with West syndrome.

Q4 Medicine
No To Hattatsu Pub Date : 2016-07-01
Ryuki Matsuura, Shin-ichiro Hamano, Yuko Hirata, Atsuko Oba, Yuji Kumagai, Kotoko Suzuki, Reiko Koichihara, Kenjiro Kikuchi, Manabu Tanaka, Motoyuki Minamitani
{"title":"Alteration of cytokines in serum and cerebrospinal fluid before and after high-dose immunoglobulin therapy in patients with West syndrome.","authors":"Ryuki Matsuura,&nbsp;Shin-ichiro Hamano,&nbsp;Yuko Hirata,&nbsp;Atsuko Oba,&nbsp;Yuji Kumagai,&nbsp;Kotoko Suzuki,&nbsp;Reiko Koichihara,&nbsp;Kenjiro Kikuchi,&nbsp;Manabu Tanaka,&nbsp;Motoyuki Minamitani","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Objective: To elucidate the pathophysiology of West syndrome and mechanism of immunoglobulin therapy for this syndrome, we investigated serum and cerebrospinal fluid (CSF) cytokine levels before and after high-dose intravenous immunoglobulin (IVIG) therapy in patients with West syndrome. Methods: We measured serum and CSF cytokine levels of 11 patients with West syndrome who was referred to Saitama Children’s Medical Center from April 2010 to May 2014. All patients received IVIG, ranging from 200 to 500 mg/kg/day for 3 consecutive days (initial IVIG treatment), before adrenocorticotrophic hormone therapy. When spasms disappeared within 2 weeks after initial IVIG treatment, maintenance IVIG treatment was commenced. We measured cytokines level in patients before and after initial IVIG treatment. We compared the levels of cytokines (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-17, Interferon γ, Granulocyte macrophage colony stimulating factor, IL-18, Tumor necrosis factor-α〔TNF-α〕) in serum and CSF, and between the seizure-free group and seizure-persisting group. Seizure free was defined as remission of spasms within 2 weeks after initial IVIG treatment and no relapse for at least 1 week after remission. Results: After IVIG therapy, 5 of 11 patients were in the seizure-free group (4 males, 1 cryptogenic) while 6 were in the seizure-persisting group (2 males, 1 cryptogenic). Levels of IL-1β, IL-10, IL-18, and TNF-α in serum were significantly higher than those in CSF before initiation of IVIG. Before IVIG treatment, the level of IL-8 in CSF was significantly higher than that in serum, while the serum IL-18 level in the seizure-free group was significantly lower than that in the seizure-persisting group. Alterations of serum IL-18 level and CSF IL-8 level were different between the seizure-free and seizure-persisting groups. Conclusions: Serum IL-18 and CSF IL-8 may be important factors for elucidating the pathophysiology of West syndrome and mechanism of IVIG therapy.</p>","PeriodicalId":39367,"journal":{"name":"No To Hattatsu","volume":"48 4","pages":"247-51"},"PeriodicalIF":0.0000,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"No To Hattatsu","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To elucidate the pathophysiology of West syndrome and mechanism of immunoglobulin therapy for this syndrome, we investigated serum and cerebrospinal fluid (CSF) cytokine levels before and after high-dose intravenous immunoglobulin (IVIG) therapy in patients with West syndrome. Methods: We measured serum and CSF cytokine levels of 11 patients with West syndrome who was referred to Saitama Children’s Medical Center from April 2010 to May 2014. All patients received IVIG, ranging from 200 to 500 mg/kg/day for 3 consecutive days (initial IVIG treatment), before adrenocorticotrophic hormone therapy. When spasms disappeared within 2 weeks after initial IVIG treatment, maintenance IVIG treatment was commenced. We measured cytokines level in patients before and after initial IVIG treatment. We compared the levels of cytokines (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-17, Interferon γ, Granulocyte macrophage colony stimulating factor, IL-18, Tumor necrosis factor-α〔TNF-α〕) in serum and CSF, and between the seizure-free group and seizure-persisting group. Seizure free was defined as remission of spasms within 2 weeks after initial IVIG treatment and no relapse for at least 1 week after remission. Results: After IVIG therapy, 5 of 11 patients were in the seizure-free group (4 males, 1 cryptogenic) while 6 were in the seizure-persisting group (2 males, 1 cryptogenic). Levels of IL-1β, IL-10, IL-18, and TNF-α in serum were significantly higher than those in CSF before initiation of IVIG. Before IVIG treatment, the level of IL-8 in CSF was significantly higher than that in serum, while the serum IL-18 level in the seizure-free group was significantly lower than that in the seizure-persisting group. Alterations of serum IL-18 level and CSF IL-8 level were different between the seizure-free and seizure-persisting groups. Conclusions: Serum IL-18 and CSF IL-8 may be important factors for elucidating the pathophysiology of West syndrome and mechanism of IVIG therapy.

西氏综合征患者高剂量免疫球蛋白治疗前后血清和脑脊液细胞因子的变化
目的:通过观察大剂量静脉注射免疫球蛋白(IVIG)治疗西综合征患者前后血清和脑脊液(CSF)细胞因子水平,探讨西综合征的病理生理及免疫球蛋白治疗西综合征的机制。方法:对2010年4月至2014年5月在埼玉儿童医疗中心转诊的11例West综合征患者进行血清和脑脊液细胞因子水平测定。所有患者在接受促肾上腺皮质激素治疗前均接受IVIG治疗,剂量为200 - 500mg /kg/天,连续3天(初始IVIG治疗)。当痉挛在初始IVIG治疗后2周内消失时,开始维持IVIG治疗。我们测量了患者在初始IVIG治疗前后的细胞因子水平。比较无发作组和持续发作组血清和脑脊液中细胞因子(IL-1β、IL-2、IL-4、IL-5、IL-6、IL-8、IL-10、IL-17、干扰素γ、粒细胞巨噬细胞集落刺激因子、IL-18、肿瘤坏死因子-α [TNF-α])水平。无癫痫发作被定义为在初始IVIG治疗后2周内痉挛缓解,缓解后至少1周内没有复发。结果:经IVIG治疗后,11例患者中无癫痫发作组5例(男性4例,隐性1例),持续癫痫发作组6例(男性2例,隐性1例)。血清IL-1β、IL-10、IL-18、TNF-α水平明显高于IVIG开始前的CSF水平。IVIG治疗前,脑脊液中IL-8水平显著高于血清中IL-8水平,无发作组血清IL-18水平显著低于持续发作组。无发作组和持续发作组血清IL-18和脑脊液IL-8水平变化差异有统计学意义。结论:血清IL-18和CSF IL-8可能是阐明西证病理生理和IVIG治疗机制的重要因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
No To Hattatsu
No To Hattatsu Medicine-Pediatrics, Perinatology and Child Health
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信